Episode Details

BiomeBank Secures $15M Investment from Blackmores for Global Microbiome Tech Expansion

Adelaide biotech BiomeBank has secured a significant investment of $15 million from Blackmores, a powerhouse in natural supplements. This funding will fuel BiomeBanks global expansion, focusing on microbiome technology for gut health solutions to chronic issues. Blackmores, founded in 1932 and recently acquired by Kirin Holdings for $1.9 billion, is making its first move into health science outside Japan through this investment. BiomeBank, founded in 2018, specializes in restoring lost beneficial microbes and received the worlds first regulatory nod in 2022 for a donor-based therapy. With this backing, BiomeBank plans to develop next-gen products and expand internationally, capitalizing on the growing global interest in microbiome solutions for improved health.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/9e190820869a5fc1